The 2-Minute Rule for Conolidine Proleviate for Joint Pain Treatment
Conolidine’s analgesic outcomes stem from its interaction with non-opioid pain pathways. Unlike opioids, which bind to µ-opioid receptors within the central anxious program, conolidine modulates alternate molecular targets. A Science Innovations study located that conolidine interacts Along with the atypical chemokine receptor ACKR3/CXCR7, which